Search

Biotech company ADmit Therapeutics has announced its move to new state-of-the-art facilities at “The Hive”, Almirall’s innovation hub in Sant Feliu de Llobregat. This strategic relocation strengthens

The biotechnology company Viva In Vitro Diagnostics shares its experience during the CDTI and FECYT workshop, offering insight into accessing one of the EU’s most competitive programmes for disruptive

BCN HEALTH presented the study “Economic evaluation of TIL-ACT with HD-IL-2: a systematic literature review of costs and cost-effectiveness” on June 19 in Madrid during the Annual Conference of the

La llegada de Mayte Alonso al equipo de PVpharm marca un paso más en la estrategia de expansión de la compañía en el ámbito de los servicios farmacéuticos globales.

The ENS certificate obtained in the audit carried out by AENOR guarantees that NorayBio has the necessary security measures to protect its information systems, data and electronic services

In collaboration with the European ShapingBio consortium, of which AseBio is a member, the event brought together key players from across the European ecosystem who emphasized the urgent need for

Dr María Navalón recently defended her doctoral thesis at IQS, in which she developed and perfected advanced microscopy methods to understand the behaviour of nanoparticles in the field of

Meet our new member SmartBio Analytics. Meet our new member Rafael Terán, General Manager.

Traditional fermented foods and beverages play a vital role in the diets of millions around the world, especially in developing countries.

PORTICO-2 designed to validate vafidemstat’s efficacy in reducing aggression in BPD patients.

Our contribution addresses the sector’s main challenges with proposals focused on three pillars: agile funding for innovation, simpler and faster regulation, and a more cohesive and globally

GENESIS Biomed provides specialised services in the valuation and search for licensees or acquirers for biomedical projects.

BeCytes Biotechnologies, a company specialized in the research and development of in vitro cellular models, has launched a new laboratory at the Barcelona Science Park (PCB) to expand its production

Oryzon’s CSO, Dr. Jordi Xaus, will participate in a Panel entitled “Industry Perspectives Discussion” on June 27.